Would pharma whistleblower bounties help or hurt the war on aging?

Claiming that “big pharma has developed a cure for cancer and is hiding it” has been a long standing cliche of conspiratorial thinking. But let’s suppose for a moment that it is possible, and market reasons can cause the pharma industry to shelve promising general anti-cancer and longevity drugs for decades. Even if these drugs eventually surface back, or a different industry re-discovers them, wouldn’t it be good to get these drugs decades early?

Argument for: GLP-1 drugs, the current wave of anti-obesity drugs, were famously discovered in the 90s but shelved for market reasons. Jeffrey S. Flier talks about this.

Argument against: IP leakage pressure may cause the industry to abandon longevity measurements altogether. No reason to R&D in something where you can’

My thought is that such whistleblower reward program may be possible, but the targets need to be chosen selectively